Literature DB >> 21208663

A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.

B Wagner1, H Freer, A Rollins, H N Erb.   

Abstract

Lyme disease is a zoonotic, vector-borne disease affecting humans, dogs, horses and other species. It is caused by infection with spirochetes of the Borrelia burgdorferi sensu lato group which are transmitted to the mammalian host by infected ticks (Ixodes). Exposure to B. burgdorferi is commonly diagnosed by serological testing. The gold standard for the detection of antibodies to B. burgdorferi is a two-step procedure of an ELISA followed by confirmatory Western blotting (WB). Here, we developed and validated a new bead-based multiplex assay for the detection of antibodies to B. burgdorferi in canine serum which combined the testing by ELISA and WB in a single quantitative test. B. burgdorferi outer surface protein A (OspA), OspC and OspF were expressed in E. coli. The recombinant proteins were coupled to fluorescent beads providing the matrix of the assay. Two sets of canine sera were used for validation of the multiplex assay. First, sera from 79 dogs with known ELISA and WB results were used to establish the conditions of the assay. These samples were selected to provide similar numbers of pre-tested sera ranging from negative to high positive results and included sera from vaccinated and/or naturally infected dogs. A high correlation was observed for detection of antibodies to B. burgdorferi in the single and multiplex assays (n=79). Spearman's rank correlations were 0.93, 0.88 and 0.96 for OspA, OspC and OspF, respectively. Second, a total of 188 canine serum samples that were not tested previously were used for further multiplex assay validation. All samples were also blindly analyzed for antibodies to B. burgdorferi antigens by WB. The WB results provided a 'relative gold standard' for each antigen and were used to perform a receiver operating curve analysis. The areas under the curves were 0.93 for OspA, 0.82 for OspC, and 0.89 for OspF. Multiplex assay interpretation ranges for antibodies to all three B. burgdorferi antigens in canine serum were established by likelihood analysis. The diagnostic sensitivities of the individual OspA, OspC and OspF bead-based assays were 83%, 62% and 82%, respectively, and the diagnostic specificities were 90%, 89% and 86%, respectively. The new multiplex assay provides a sensitive and fully quantitative platform for the simultaneous evaluation of antibodies to B. burgdorferi OspA, OspC and OspF antigens and distinguishes between antibodies that originated from vaccination or natural exposure to B. burgdorferi.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21208663     DOI: 10.1016/j.vetimm.2010.12.003

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  16 in total

1.  Antibodies to Borrelia burgdorferi OspA, OspC, OspF, and C6 antigens as markers for early and late infection in dogs.

Authors:  Bettina Wagner; Heather Freer; Alicia Rollins; David Garcia-Tapia; Hollis N Erb; Christopher Earnhart; Richard Marconi; Patrick Meeus
Journal:  Clin Vaccine Immunol       Date:  2012-02-15

2.  Diversity of antibody responses to Borrelia burgdorferi in experimentally infected beagle dogs.

Authors:  Elisabeth Baum; Deborah A Grosenbaugh; Alan G Barbour
Journal:  Clin Vaccine Immunol       Date:  2014-04-02

3.  Five-Antigen Fluorescent Bead-Based Assay for Diagnosis of Lyme Disease.

Authors:  Monica E Embers; Nicole R Hasenkampf; Mary B Barnes; Elizabeth S Didier; Mario T Philipp; Amanda C Tardo
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

4.  Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens.

Authors:  Bartholomew N Ondigo; Gregory S Park; Severin O Gose; Benjamin M Ho; Lyticia A Ochola; George O Ayodo; Ayub V Ofulla; Chandy C John
Journal:  Malar J       Date:  2012-12-21       Impact factor: 2.979

5.  Retrospective Evaluation of Horses Diagnosed with Neuroborreliosis on Postmortem Examination: 16 Cases (2004-2015).

Authors:  L K Johnstone; J B Engiles; H Aceto; V Buechner-Maxwell; T Divers; R Gardner; R Levine; N Scherrer; D Tewari; J Tomlinson; A L Johnson
Journal:  J Vet Intern Med       Date:  2016-06-21       Impact factor: 3.333

6.  ACVIM consensus update on Lyme borreliosis in dogs and cats.

Authors:  Meryl P Littman; Bernhard Gerber; Richard E Goldstein; Mary Anna Labato; Michael R Lappin; George E Moore
Journal:  J Vet Intern Med       Date:  2018-03-22       Impact factor: 3.333

7.  Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.

Authors:  Deborah A Grosenbaugh; Karelle De Luca; Pierre-Yves Durand; Bradley Feilmeier; Kristopher DeWitt; Cecile Sigoillot-Claude; Marie-Line Sajous; Michael J Day; Frederic David
Journal:  BMC Vet Res       Date:  2018-10-16       Impact factor: 2.741

8.  Susceptibility of white-tailed deer (Odocoileus virginianus) to SARS-CoV-2.

Authors:  Mitchell V Palmer; Mathias Martins; Shollie Falkenberg; Alexandra Buckley; Leonardo C Caserta; Patrick K Mitchell; Eric D Cassmann; Alicia Rollins; Nancy C Zylich; Randall W Renshaw; Cassandra Guarino; Bettina Wagner; Kelly Lager; Diego G Diel
Journal:  J Virol       Date:  2021-03-10       Impact factor: 6.549

9.  Evaluation of 2 ELISAs to determine Borrelia burgdorferi seropositivity in horses over a 12-month period.

Authors:  Megan Neely; Luis Arroyo; Claire Jardine; Katie Clow; Alison Moore; Murray Hazlett; J Scott Weese
Journal:  J Vet Diagn Invest       Date:  2021-05-27       Impact factor: 1.279

10.  Measurement of Soluble Biomarkers by Flow Cytometry.

Authors:  Péter Antal-Szalmás; Béla Nagy; Ildikó Beke Debreceni; János Kappelmayer
Journal:  EJIFCC       Date:  2013-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.